Home/Filings/4/0001562180-20-005316
4//SEC Filing

Davidson David 4

Accession 0001562180-20-005316

CIK 0001293971other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 4:06 PM ET

Size

7.2 KB

Accession

0001562180-20-005316

Insider Transaction Report

Form 4
Period: 2020-08-03
Davidson David
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2020-08-03$60.32/sh31$1,87039,819 total
  • Sale

    Common Stock

    2020-08-03$61.98/sh11$68239,808 total
Footnotes (3)
  • [F1]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F2]The range in prices for the transaction reported on this line was $59.75 to $60.72. The average weighted price was $60.3182. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]The range in prices for the transaction reported on this line was $60.83 to $61.00. The average weighted price was $60.9811. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

bluebird bio, Inc.

CIK 0001293971

Entity typeother

Related Parties

1
  • filerCIK 0001578696

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:06 PM ET
Size
7.2 KB